γ -H2AX: A novel prognostic marker in a prognosis prediction model of patients with early operable non-small cell lung cancer

International Journal of Genomics

Volumn 2014, Issue , 2014, Pages

  Chatzimichail, E ^a   Matthaios, D ^a   Bouros, D ^a   Karakitsos, P ^b   Romanidis, K ^a   Kakolyris, S ^a   Papashinopoulos, G ^a   Rigas, A ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA HISTONE H2AX; HISTONE H2AX; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DAMAGE; EARLY CANCER; FEMALE; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL ANALYSIS; SURVIVAL PREDICTION; VALIDATION PROCESS; VERY ELDERLY;

EID: 84893415469     PISSN: 2314436X     EISSN: 23144378     Source Type: Journal    
DOI: 10.1155/2014/160236     Document Type: Article

References (35)

1. Pandey B., Mishra R. B., Knowledge and intelligent computing system in medicine. Computers in Biology and Medicine 2009 39 3 215 230 2-s2.0-60649093460 10.1016/j.compbiomed.2008.12.008
2. Gómez-Ruiz J. A., Jerez-Aragonés J. M., Muñoz-Pérez J., Alba-Conejo E., A neural network based model for prognosis of early breast cancer. Applied Intelligence 2004 20 231 238
3. Er O., Yumusak N., Temurtas F., Chest diseases diagnosis using artificial neural networks. Expert Systems with Applications 2010 37 12 7648 7655 2-s2.0-77957857208 10.1016/j.eswa.2010.04.078
4. Saritas I., Prediction of breast cancer using artificial neural networks. Journal of Medical Systems 2011 36 5 2901 2907 2-s2.0-81155158392 10.1007/s10916-011-9768-0
5. Feng F., Wu Y., Wu Y., Nie G., Ni R., The effect of artificial neural network model combined with six tumor markers in auxiliary diagnosis of Lung Cancer. Journal of Medical Systems 2011 36 2973 2980 2-s2.0-80052114313 10.1007/s10916-011-9775-1
6. Siegel R., Ward E., Brawley O., Jemal A., Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA-Cancer Journal for Clinicians 2011 61 4 212 236 2-s2.0-80051580618 10.3322/caac.20121
7. Goldstraw P., Ball D., Jett J. R., Le Chevalier T., Lim E., Nicholson A. G., Shepherd F. A., Non-small-cell lung cancer. The Lancet 2011 378 9804 1727 1740 2-s2.0-81055157135 10.1016/S0140-6736(10)62101-0
8. Stephan C., Cammann H., Rittenhouse H., Lein M., Jentzmik F., Schrader M., Deger S., Miller K., Jung K., New biomarkers and application of multivariate models for detection of prostate cancer. Aktuelle Urologie 2009 40 4 221 230 2-s2.0-70049096842 10.1055/s-0029-1224535
9. Cagini L., Monacelli M., Giustozzi G., Mozzi L., Bellezza G., Sidoni A., Bucciarelli E., Darwish S., Ludovini V., Pistola L., Gregorc V., Tonato M., Biological prognostic factors for early stage completely resected non-small cell lung cancer. Journal of Surgical Oncology 2000 74 53 60 (Pubitemid 30387224)
10. Gönen M., Bias, biostatistics, and prognostic factors. Journal of Thoracic Oncology 2011 6 7 S1705 S1709 2-s2.0-79959853559 10.1097/JTO. 0b013e31821e7ae7
11. Hu Q., Li B., Garfield D., Ren S., Li A., Chen X., Zhou C., Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: a regional, single-institution, retrospective analysis of 4552 patients. Thoracic Cancer 2012 3 162 168
12. Dickey J. S., Redon C. E., Nakamura A. J., Baird B. J., Sedelnikova O. A., Bonner W. M., H2AX: functional roles and potential applications. Chromosoma 2009 118 6 683 692 2-s2.0-70450224676 10.1007/s00412-009-0234-4
13. Podhorecka M., Skladanowski A., Bozko P., H2AX phosphorylation: its role in DNA damage response and cancer therapy. Journal of Nucleic Acids 2010 2010 9 920161 10.4061/2010/920161
14. Matthaios D., Bouros D., Kakolyris S., H2AX and lung cancer:is it the Ariadne's thread? DNA Repair 2013 12 2 90 91
15. Beane J., Sebastiani P., Whitfield T. H., Steiling K., Dumas Y.-M., Lenburg M. E., Spira A., A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prevention Research 2008 1 1 56 64 2-s2.0-52649131476 10.1158/1940-6207.CAPR-08-0011
16. Santos-García G., Varela G., Novoa N., Jiménez M. F., Prediction of postoperative morbidity after lung resection using an artificial neural network ensemble. Artificial Intelligence in Medicine 2004 30 1 61 69 2-s2.0-0346848887 10.1016/S0933-3657(03)00059-9 (Pubitemid 37543648)
17. Bartfay E., Mackillop W. J., Pater J. L., Comparing the predictive value of neural network models to logistic regression models on the risk of death for small-cell lung cancer patients. European Journal of Cancer Care 2006 15 2 115 124 2-s2.0-33645715554 10.1111/j.1365-2354.2005.00638.x (Pubitemid 43542752)
18. Bishop C. M., Neural Networks for Pattern Recognition 1995 New York, NY, USA Oxford University Press
19. Balachandran K., Anitha R., Supervised learning processing techniques for pre-diagnosis of lung cancer disease. International Journal of Computer Applications 2010 1, article 17
20. Schwarzer G., Vach W., Schumacher M., On the misuses of artificial neural networks for prognostic and diagnostic classification in oncology. Statistics in Medicine 2000 19 541 561 (Pubitemid 30126883)
21. Lisboa P. J. G., A review of evidence of health benefit from artificial neural networks in medical intervention. Neural Networks 2002 15 1 11 39 2-s2.0-0036127092 (Pubitemid 34234792)
22. Grumett S. A., Snow P. B., Artificial neural networks: a new model for assessing prognostic factors. Annals of Oncology 2000 11 4 383 384 2-s2.0-0034069985 10.1023/A:1008344718234 (Pubitemid 30333538)
23. Biganzoli E., Boracchi P., Coradini D., Daidone M. G., Marubini E., Prognosis in node-negative primary breast cancer: a neural network analysis of risk profiles using routinely assessed factors. Annals of Oncology 2003 14 10 1484 1493 2-s2.0-0142216643 10.1093/annonc/mdg422 (Pubitemid 37304602)
24. Chatzimichail E., Paraskakis E., Sitzimi M., Rigas A., Predicting the long-term outcome of preschool children with asthma symptoms. Proceedings of the E-Health and Bioengineering Conference (EHB '11) November 2011 1 4 2-s2.0-84857831299
25. Ciampi A., Zhang F., A new approach to training back-propagation artificial neural networks: empirical evaluation on ten data sets from clinical studies. Statistics in Medicine 2002 21 9 1309 1330 2-s2.0-0037094082 10.1002/sim.1107 (Pubitemid 34467236)
26. Van Belle V., Pelckmans K., Suykens J. A. K., Van Huffel S., Additive survival least-squares support vector machines. Statistics in Medicine 2010 29 2 296 308 2-s2.0-74749107874 10.1002/sim.3743
27. Chatzimichail E. A., Rigas A. G., Paraskakis E. N., An artificial intelligence technique for the prediction of persistent asthma in children. Proceedings of the 10th International Conference on Information Technology and Applications in Biomedicine (ITAB '10) November 2010 1 4 2-s2.0-79951612900 10.1109/ITAB.2010.5687810
28. Pagano E., Filippini C., Di Cuonzo D., Ruffini E., Zanetti R., Rosso S., Bertetto O., Merletti F., Ciccone G., Factors affecting pattern of care and survival in a population-based cohort of non-small-cell lung cancer incident cases. Cancer Epidemiology 2010 34 4 483 489 2-s2.0-77955090711 10.1016/j.canep.2010.04.002
29. Liu L., Zhao E., Li C., TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. Cancer Epidemiology 2013 37 71 78
30. Biganzoli E., Boracchi P., Mariani L., Marubini E., Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach. Statistics in Medicine 1998 17 1169 1186 (Pubitemid 28221032)
31. Mehta C. R., Patel N. R., Exact logistic regression: theory and examples. Statistics in Medicine 1995 14 19 2143 2160 2-s2.0-0029022967
32. Tu J. V., Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. Journal of Clinical Epidemiology 1996 49 11 1225 1231 2-s2.0-0030297904 10.1016/S0895-4356(96)00002-9 (Pubitemid 26386228)
33. Eftekhar B., Mohammad K., Ardebili H. E., Ghodsi M., Ketabchi E., Comparison of artificial neural network and logistic regression models for prediction of mortality in head trauma based on initial clinical data. BMC Medical Informatics and Decision Making 2005 5, article 3 2-s2.0-15244347342 10.1186/1472-6947-5-3 (Pubitemid 40390011)
34. Sargent D. J., Comparison of artificial neural networks with other statistical approaches: results from medical data sets. Cancer 2001 91 8, supplement 1636 1642 2-s2.0-0035871395 (Pubitemid 32319240)
35. Matthaios D., Foukas P. G., Kefala M., Hountis P., Trypsianis G., Panayiotides I. G., Chatzaki E., Pantelidaki E., Bouros D., Karakitsos P., Kakolyris S., γ -H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. OncoTargets and Therapy 2012 5 309 314